Application of transient elastometry to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patients

Journal of Hepatology

Volumn 49, Issue 6, 2008, Pages 916-922

  Macías, Juan ^a,k   Recio, Eva ^b,k   Vispo, Eugenia ^c   Rivero, Antonio ^d,k   López Cortés, Luis F ^e,k   Ríos, M José ^f,k   Merino, Dolores ^g,k   González, Mercedes ^h,k   Barreiro, Pablo ^c   de Lédinghen, Victor ⁱ   Quereda, Carmen ^j   Pineda, Juan A ^b,k  

^a Unit of Infectious Diseases   (Spain)

^b HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^f HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^g HOSPITAL JUAN RAMÓN JIMÉNEZ   (Spain)

^h HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

ⁱ HAUT LÉVÊQUE HOSPITAL   (France)

^j HOSPITAL RAMÓN Y CAJAL   (Spain)

^k Grupo para el Estudio de las Hepatitis Viricas de la Sociedad Andaluza de Enfermedades Infecciosas   (Spain)

more..

Author keywords

Co infection; HCV; HIV; Liver fibrosis; Transient elastometry

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; FEMALE; GENOTYPE; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MIXED INFECTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TRANSIENT ELASTOMETRY;

AGED; BIOPSY; DIAGNOSTIC TECHNIQUES, DIGESTIVE SYSTEM; ELASTICITY; FEMALE; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 55549116657     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.07.031     Document Type: Article

References (26)

1. Pineda J.A., García-García J.A., Aguilar-Guisado M., Ríos-Villegas M.J., Ruiz-Morales J., Rivero A., et al. Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy. Hepatology 46 (2007) 622-630
2. Torriani F.J., Rodríguez-Torres M., Rockstroh J.K., Lissen E., González-García J., Lazzarin A., et al. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med 351 (2004) 438-450
3. Carrat F., Bani-Sadr F., Pol S., Rosenthal E., Lunel-Fabiani F., Benzekri A., et al. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. JAMA 292 (2004) 2839-2848
4. Mauss S. Treatment of viral hepatitis in HIV-coinfected patients-adverse events and their management. J Hepatol 44 (2006) S114-S118
5. Alberti A., Clumeck N., Collins S., Gerlich W., Lundgren J., Palu G., et al. Short statement of the first European consensus conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. J Hepatol 42 (2005) 615-624
6. Nelson M, Matthews G, Brook MG, Main J. BHIVA Coinfection Guideline Committee; British HIV Association. BHIVA guidelines on HIV and chronic hepatitis: coinfection with HIV and hepatitis C virus infection (2005). HIV Med 2005;6 (Suppl. 2): 96-106.
7. Aranzabal L., Casado J.L., Moya J., Quereda C., Diz S., Moreno A., et al. Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection. Clin Infect Dis 40 (2005) 588-593
8. Mira J.A., Macías J., Girón-González J.A., Merino D., González-Serrano M., Jiménez-Mejías M.E., et al. Incidence of and risk factors for severe hepatotoxicity of nelfinavir-containing regimens among HIV-infected patients with chronic hepatitis C. J Antimicrob Chemother 58 (2006) 140-146
9. Labarga P., Soriano V., Vispo M.E., Pinilla J., Martin-Carbonero L., Castellares C., et al. Hepatotoxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-infected patients. J Infect Dis 196 (2007) 670-676
10. Van Thiel D.H., Gavaler J.S., Wright H., and Tzakis A. Liver biopsy. Its safety and complications as seen at a liver transplant center. Transplantation 55 (1993) 1087-1090
11. Wong J.B., and Koff R.S. Watchful waiting with periodic liver biopsy versus immediate empirical therapy for histologically mild chronic hepatitis C. A cost-effectiveness analysis. Ann Intern Med 133 (2000) 665-675
12. Bedossa P., Dargere D., and Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38 (2003) 1449-1457
13. Rousselet M.C., Michalak S., Dupre F., Croue A., Bedossa P., Saint-Andre J.P., et al. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 41 (2005) 257-264
14. Ziol M., Handra-Luca A., Kettaneh A., Christidis C., Mal F., Kazemi F., et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with hepatitis C. Hepatology 41 (2005) 48-54
15. Castéra L., Vergniol J., Foucher J., Le Bail B., Chanteloup E., Hasser M., et al. Prospective comparison of transient elastography, fibrostest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128 (2005) 343-350
16. Foucher J., Chanteloup E., Vergniol J., Castéra L., Le Bail B., Adhoute X., et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 55 (2006) 403-408
17. De Lédinghen V., Douvin C., Ketttaneh A., Ziol M., Roulot D., Marcellin P., et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr 41 (2006) 175-179
18. Vergara S., Macías J., Rivero A., Gutiérrez-Valencia A., González-Serrano M., Merino D., et al. The utility of transient elastometry in assessing liver fibrosis in patients with HIV/HCV coinfection. Clin Infect Dis 45 (2007) 969-974
19. Sandrin L., Fourquet B., Hasquenoph J.M., Yon S., Fournier C., Mal F., et al. Transient elastography: a new non-invasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 29 (2003) 1705-1713
20. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994; 20: 15-20.
21. Barreiro P., Martín-Carbonero L., Núñez M., Rivas P., Morente A., Simarro N., et al. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3. Clin Infect Dis 42 (2006) 1032-1039
22. Irwig L., Bossuyt P., Glasziou P., Gatsonis C., and Lijmer J. Designing studies to ensure that estimates of test accuracy are transferable. BMJ 324 (2002) 669-671
23. Macías J., Girón-González J.A., González-Serrano M., Merino D., Cano P., Mira J.A., et al. Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes. Gut 55 (2006) 409-414
24. Myers R.P., Benhamou Y., Imbert-Bismut F., Thibault V., Bochet M., Charlotte F., et al. Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients. AIDS 17 (2003) 721-725
25. del Valle J, Macías J, Barreiro P, et al. Improving the differentiation of mild from significant liver fibrosis in HIV/HCV-co-infected patients using transient elastometry. In: 15th conference on retroviruses and opportunistic infections. Boston, USA, 2008. [Abstract 1053]..
26. Nuñez M. Hepatotoxicity of antiretrovirals: incidence, mechanisms and management. J Hepatol 44 (2006) S132-S139